These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 6774945)

  • 41. Studies on commercial typhus vaccines. IV. The chemical composition of the antigens of commercial typhus vaccine.
    COHEN SS
    J Immunol; 1950 Nov; 65(5):475-83. PubMed ID: 14794911
    [No Abstract]   [Full Text] [Related]  

  • 42. How Charles Nicolle of the Pasteur Institute discovered that epidemic typhus is transmitted by lice: reminiscences from my years at the Pasteur Institute in Paris.
    Gross L
    Proc Natl Acad Sci U S A; 1996 Oct; 93(20):10539-40. PubMed ID: 8855211
    [No Abstract]   [Full Text] [Related]  

  • 43. The constitution of that rickettsia and soluble rickettsial antigen derived from the epidemic typhus vaccine.
    COHEN SS
    Fed Proc; 1946; 5(1 Pt 2):129. PubMed ID: 21066650
    [No Abstract]   [Full Text] [Related]  

  • 44. [Immunization of man against epidemic typhus by infection with avirulent "Rickettsia prowazekii" (strain E)].
    FOX JP; MONTOYA JA; JORDAN ME; CORNEJO UBILLUS JR; LLOSA GARCIA J; ARCE ESTRADA M; GELFAND HM; HERRERA L
    Rev Sanid Hig Publica (Madr); 1961; 35():481-512. PubMed ID: 13894378
    [No Abstract]   [Full Text] [Related]  

  • 45. [Pathomorphology of local reactions to typhus exanthematosus vaccine following sedimentation].
    GINDIN AP; IATSIMIRSKAIA-KRONTOVSKAIA MK; ZHIV BV; SALAGOVA TA
    Zh Mikrobiol Epidemiol Immunobiol; 1955 Jul; (7):69-71. PubMed ID: 13257798
    [No Abstract]   [Full Text] [Related]  

  • 46. [Immunoenzyme analysis in a system of serologic evaluation of louse-borne typhus vaccines].
    Pshenichnov VA; Kutuzov VA; Kruglova SE; Kirillov AP; Mikhaĭlov VV
    Zh Mikrobiol Epidemiol Immunobiol; 1988 Sep; (9):79-82. PubMed ID: 3144818
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Characteristics of the causative agent of Brill's disease (brief research results)].
    Krasnik FI
    Tr Inst Im Pastera; 1975; 43():99-109. PubMed ID: 829916
    [No Abstract]   [Full Text] [Related]  

  • 48. Studies on commercial typhus vaccines. III. The concentration and isolation of the Rickettsia-specific soluble antigen of commercial typhus vaccine.
    COHEN SS; CHAMBERS LA; CLAWSON JR
    J Immunol; 1950 Nov; 65(5):465-73. PubMed ID: 14794910
    [No Abstract]   [Full Text] [Related]  

  • 49. Immunization against epidemictyphus by strain e vaccine. (Avirulent Ricksettsia prowazwki) in Egypt. II. Observation as to post-vaccination reactions and sero-immune response in an opne community.
    Imam ZE; Alfy L; Shoukry B; el-Rai F; Hegab S; Hosny A
    J Egypt Public Health Assoc; 1965; 40(6):483-93. PubMed ID: 4974737
    [No Abstract]   [Full Text] [Related]  

  • 50. [Immunization of man against typhus epidemics by injections of avirulent Rickettsia prowazeki (CEPAE). Brief analysis with observations during a period of 3 years and averages as to the occurrence of typhus between vaccinated individuals and the control population in the zone on the Andes Peruanos. (Distrito de Ilave, Departamento de Puno)].
    FOX JP; MONTOYA JA; JORDAN ME; CORNEJO UBILLUS JR; GARCIA JL; ESTRADA MA; GELFAND HM; HERRERA L
    Bol Oficina Sanit Panam; 1961 Sep; 51():215-35. PubMed ID: 13701107
    [No Abstract]   [Full Text] [Related]  

  • 51. Antigenic relationships between the typhus and spotted fever groups of rickettsiae.
    Ormsbee R; Peacock M; Philip R; Casper E; Plorde J; Gabre-Kidan T; Wright L
    Am J Epidemiol; 1978 Jul; 108(1):53-9. PubMed ID: 99029
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Typhus group Rickettsiae antibodies in rural Mexico.
    Alcantara VE; Gallardo EG; Hong C; Walker DH
    Emerg Infect Dis; 2004 Mar; 10(3):549-51. PubMed ID: 15116713
    [No Abstract]   [Full Text] [Related]  

  • 53. [The need for a review of the procedure for the preventive vaccination of researchers working with Rickettsia prowazekii].
    Ignatovich VF; Kekcheeva NK; Genig VA; Balaeva NM; Eremeeva ME; Belousova LS; Penkina GA; Umnova MS; Tupitsyn AV; Tarasevich IV
    Zh Mikrobiol Epidemiol Immunobiol; 1999; (2):52-6. PubMed ID: 10356738
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Development of Rickettsia prowazekii DNA vaccine: cloning strategies.
    Coker C; Majid M; Radulovic S
    Ann N Y Acad Sci; 2003 Jun; 990():757-64. PubMed ID: 12860719
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Doxycycline in experimental rickettsial infection].
    Kekcheeva NG
    Antibiotiki; 1984 Oct; 29(10):775-80. PubMed ID: 6439108
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Immunogenic properties of Rickettsia prowazekii strain E. II. Antitoxic immunity].
    IABLONSKAIA VA
    Vopr Virusol; 1959; 4(3):266-7. PubMed ID: 13676454
    [No Abstract]   [Full Text] [Related]  

  • 57. Medical science in the light of the Holocaust: Departing from a post-war paper by Ludwik Fleck.
    Hedfors E
    Soc Stud Sci; 2008 Apr; 38(2):259-83. PubMed ID: 18831133
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Complement-fixing antibodies for R. prowazeki in domestic animals sera collected in typhus fever endemic areas in the SR of Serbia.
    Pecic J; Borjanovic S; Eremic R
    G Mal Infett Parassit; 1971 Nov; 23(11):1024-6. PubMed ID: 5004850
    [No Abstract]   [Full Text] [Related]  

  • 59. Evidence of Rickettsia prowazekii infections in the United States.
    McDade JE; Shepard CC; Redus MA; Newhouse VF; Smith JD
    Am J Trop Med Hyg; 1980 Mar; 29(2):277-84. PubMed ID: 6154428
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Persistence of Rickettsia prowazekii in B mice and cotton B rats].
    Kokorin IN; Miskarova ED; Abrosimova GE; Shirokova EM; Ignatovich VF
    Vestn Akad Med Nauk SSSR; 1985; (3):44-7. PubMed ID: 3922155
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.